APW
ABBV icon

Atlantic Private Wealth’s AbbVie ABBV Stock Holding History

Atlantic Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61K Hold
12
– – ﹤0.01% 216
2025
Q4 		$2.74K Sell
12
-16
-57% -$3.65K ﹤0.01% 225
2025
Q3 		$6.48K Buy
+28
New +$5.7K ﹤0.01% 187

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atlantic Private Wealth's ABBV Position: Q1 2026 in Review

Atlantic Private Wealth held its AbbVie (ABBV) position steady in Q1 2026 at 12 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

Atlantic Private Wealth first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.48K in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Atlantic Private Wealth held 12 shares of AbbVie worth $2.61K as of Q1 2026.
  • Atlantic Private Wealth left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up ﹤0.01% of Atlantic Private Wealth's portfolio in Q1 2026, its #216 holding.
  • Atlantic Private Wealth first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • Atlantic Private Wealth's AbbVie position peaked at $6.48K in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Atlantic Private Wealth's 13F filing for Q1 2026, filed 8 May 2026.